Combination of pemetrexed with bevacizumab for non-small-cell lung cancer: a meta-analysis study

Combination of pemetrexed with bevacizumab for non-small-cell lung cancer: a meta-analysis study

Abstract Background Combining pemetrexed with bevacizumab may have some potential in improving the efficacy in patients with non-small-cell lung cancer (NSCLC), and this meta-analysis aims to explore the impact of pemetrexed addition to bevacizumab on treatment efficacy for NSCLC. Methods PubMed, EM...

Full description

Bibliographic Details
Main Authors: Wei Fang, Xingqiao Peng, Qun Zhou
Format: Article
Language:English
Published: BMC 2024-08-01
Series:Journal of Cardiothoracic Surgery
Subjects:
NSCLC
Pemetrexed
Bevacizumab
Overall survival
Progression-free survival
Online Access:https://doi.org/10.1186/s13019-024-02975-6

Internet

https://doi.org/10.1186/s13019-024-02975-6

Similar Items